| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 10001122 | ASTSDYQVISDR | S | 4 | 298 |
| 10001525 | 53 | |||
| 10009465 | ASTSDYQVISDR | S | 4 | 298 |
| 10011734 | ISTMRPLATAYKASTSDYQVISDRQTPKKDE | S | 298 | |
| 10019614 | ASTSDYQVISDR | S | 298 | |
| 10023829 | ASTSDYQVISDR | S | 4 | 298 |
| 10023830 | SISGPSVGVMEMR | S | 1 | 53 |
| 10025653 | ASTSDYQVISDR | T | 3 | 297 |
| 10026029 | ASTSDYQVISDR | S | 2 | 296 |
| 10026627 | ASTSDYQVISDR | S | 4 | 298 |
| 10027071 | SIYDDISSPGLGSTPLTSR | S | 1 | 93 |
| 10028299 | ASTSDYQVISDR | S | 2 | 296 |
| 10028663 | ASTSDYQVISDR | T | 3 | 297 |
| 10029320 | ASTSDYQVISDR | T | 3 | 297 |
| 10031086 | ASTSDYQVISDR | S | 2 | 296 |
| 10031373 | ASTSDYQVISDR | S | 4 | 298 |
| 10032011 | SISGPSVGVMEMR | S | 1 | 53 |
| 10033041 | SISGPSVGVMEMR | S | 1 | 53 |
| 10036433 | ASTSDYQVISDR | S | 296 | |
| 10036434 | ASTSDYQVISDR | S | 298 | |
| 10037458 | ASTSDYQVISDR | 296 | ||
| 10037459 | ASTSDYQVISDR | 298 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 10001122 | MS | HTP | unambiguous | human | HeLa cells | 20 uM GalNAz/200 uM GalNAz | 5.882352941 | 30059200 | ||
| 10001525 | MS | HTP | unambiguous | human | HeLa cells | Interphase/Mitosis | 100 | 34161081 | The p value was -log10p in original paper. | |
| 10009465 | MS | HTP | unambiguous | human | brain | 28657654 | ||||
| 10011734 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | ||||
| 10019614 | MS | HTP | unambiguous | human | Hela cells | 29237092 | ||||
| 10023829 | MS | HTP | unambiguous | human | THP1 cells | 32938750 | ||||
| 10023830 | MS | HTP | unambiguous | human | THP1 cells | 32938750 | ||||
| 10025653 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | ||||
| 10026029 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | ||||
| 10026627 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | ||||
| 10027071 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | ||||
| 10028299 | MS | HTP | unambiguous | human | SW480 cells | 35254053 | ||||
| 10028663 | MS | HTP | unambiguous | human | SW480 cells | 35254053 | ||||
| 10029320 | MS | HTP | unambiguous | human | SW620 cells | 35254053 | ||||
| 10031086 | MS | HTP | unambiguous | human | HeLa cell nucleus | 35289036 | ||||
| 10031373 | MS | HTP | unambiguous | human | HeLa cell nucleus | 35289036 | ||||
| 10032011 | MS | HTP | unambiguous | human | HeLa cell nucleus | 35289036 | ||||
| 10033041 | MS | HTP | unambiguous | human | Jurkat cells | 35705054 | ||||
| 10036433 | MS | HTP | unambiguous | human | HEK 293T cells | 30620550 | ||||
| 10036434 | MS | HTP | unambiguous | human | HEK 293T cells | 30620550 | ||||
| 10037458 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | -0.321928095 | 30620550 | Peptide quantification value was applied to each modification site | |
| 10037459 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | -0.321928095 | 30620550 | Peptide quantification value was applied to each modification site |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10001122 | ASTSDYQVISDR | S | 4 | 298 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | |
| 10001525 | 53 | MS | HTP | unambiguous | human | HeLa cells | 34161081 | The p value was -log10p in original paper. | |||
| 10009465 | ASTSDYQVISDR | S | 4 | 298 | MS | HTP | unambiguous | human | brain | 28657654 | |
| 10011734 | ISTMRPLATAYKASTSDYQVISDRQTPKKDE | S | 298 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | ||
| 10019614 | ASTSDYQVISDR | S | 298 | MS | HTP | unambiguous | human | Hela cells | 29237092 | ||
| 10023829 | ASTSDYQVISDR | S | 4 | 298 | MS | HTP | unambiguous | human | THP1 cells | 32938750 | |
| 10023830 | SISGPSVGVMEMR | S | 1 | 53 | MS | HTP | unambiguous | human | THP1 cells | 32938750 | |
| 10025653 | ASTSDYQVISDR | T | 3 | 297 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10026029 | ASTSDYQVISDR | S | 2 | 296 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10026627 | ASTSDYQVISDR | S | 4 | 298 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10027071 | SIYDDISSPGLGSTPLTSR | S | 1 | 93 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10028299 | ASTSDYQVISDR | S | 2 | 296 | MS | HTP | unambiguous | human | SW480 cells | 35254053 | |
| 10028663 | ASTSDYQVISDR | T | 3 | 297 | MS | HTP | unambiguous | human | SW480 cells | 35254053 | |
| 10029320 | ASTSDYQVISDR | T | 3 | 297 | MS | HTP | unambiguous | human | SW620 cells | 35254053 | |
| 10031086 | ASTSDYQVISDR | S | 2 | 296 | MS | HTP | unambiguous | human | HeLa cell nucleus | 35289036 | |
| 10031373 | ASTSDYQVISDR | S | 4 | 298 | MS | HTP | unambiguous | human | HeLa cell nucleus | 35289036 | |
| 10032011 | SISGPSVGVMEMR | S | 1 | 53 | MS | HTP | unambiguous | human | HeLa cell nucleus | 35289036 | |
| 10033041 | SISGPSVGVMEMR | S | 1 | 53 | MS | HTP | unambiguous | human | Jurkat cells | 35705054 | |
| 10036433 | ASTSDYQVISDR | S | 296 | MS | HTP | unambiguous | human | HEK 293T cells | 30620550 | ||
| 10036434 | ASTSDYQVISDR | S | 298 | MS | HTP | unambiguous | human | HEK 293T cells | 30620550 | ||
| 10037458 | ASTSDYQVISDR | 296 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site | ||
| 10037459 | ASTSDYQVISDR | 298 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site |